INSIGHTS ON CLINICAL TRIAL DESIGN

• Finding The Solution(s) That Meet The Needs Of Patients, Sites, And Sponsors

  Poor enrollment and retention often stem from patient burden and limited site access. Learn how leveraging diverse site networks and remote support can transform the clinical trial experience.

• Clinical Trial Budgeting Faces Pressure To Modernize

  Outdated budget data slows trial startup. Real-time market benchmarking helps sites and sponsors negotiate faster and get treatments to patients sooner.

• Rare Disease Development: Navigating Small Populations And Complex Protocols

  Learn how you can navigate the complexity of rare disease development with flexible trial design, integrated regulatory strategy, and data-driven execution built for small populations and global programs.

• Improving Early Phase Oncology Trial Execution With A Site-First Approach

  Trials that look good on paper often stall at the site. Learn how involving sites early in study design cuts delays and keeps early-phase cancer studies on track from startup to patients.

• How Community-Based Research Models Expand Access

  9/9/2025

  As momentum continues to grow in neurology research, how can community-based research models help overcome recruitment and retention challenges in complex areas like Alzheimer's?

• Outgrowing Excel: Implementing RTSM In A Live Phase I Trial

  2/25/2026

  Learn how a clinical-stage oncology biotech successfully transitioned a live Phase I trial from manual spreadsheets to RTSM without disrupting site momentum or patient enrollment.

• Why RWD Strategy Can't Wait With Price, Value And Evidence Pressures Everywhere

  4/27/2026

  Overcome pricing pressures and reimbursement delays by integrating real-world evidence early in development to align clinical outcomes with payer demands and accelerate patient access.

• AI-Powered Strategy Is Redefining Patient Recruitment Performance

  9/9/2025

  This AI-powered platform is helping CROs and sponsors tackle the unsolved challenge they've faced for decades: clinical trials that launch late, recruit slowly, and miss enrollment targets.

• How Adaptive Design Accelerates Early‑Phase NSCLC Development

  5/22/2026

  Adaptive trial designs and an adaptive mindset enable non-small cell lung cancer (NSCLC) sponsors to optimize dose, respond to evolving expectations, and accelerate early‑phase development.